Search Results
The Next Phase of Targeted Therapy in MCL and DLBCL
The role of stem cell transplantation in the era of targeted therapies in DLBCL and MCL
The role of ibrutinib in DLBCL and the value of next-generation BTK inhibitors
CCTG LY.17 trial: R-GDP versus R-DICEP salvage therapy in patients with R/R DLBCL
New DLBCL Clinical Trial: Epcoritamab for Diffuse Large B-Cell Lymphoma
VLS-101 in heavily pretreated MCL and DLBCL
Advancements in MCL treatment
Taking the Next Steps With Next-Generation BTKi in CLL, MCL, and DLBCL
VLS-101: an ADC for MCL and DLBCL
Parsaclisib for MCL: next steps?
Treatment Limitations in DLBCL
Dose-escalation results from Phase Ib/IIa trial of AZD4573 + acalabrutinib in R/R DLBCL
